SMTL ID : 6lvk.1 (1 other biounit)

Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.29 Å

Oligo State

monomer

Ligands

1 x EVC: N-ethyl-2-[[4-[[4-(4-methylpiperazin-1-yl)-3-(2-morpholin-4-ylethoxy)phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide(Non-covalent)

EVC.1: 20 residues within 4Å: Chain A: K.30, L.32, G.33, F.37, V.40, M.42, A.60, K.62, V.109, E.110, Y.111, A.112, S.113, G.115, E.119, R.175, N.176, L.178, A.188, D.189 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.32, A:F.37, A:V.40, A:V.40, A:L.178 Hydrogen bonds: A:K.30, A:A.112, A:A.112 Water bridges: A:E.79, A:D.189, A:D.189, A:D.189 Salt bridges: A:E.119

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 6 residues within 4Å: Chain A: R.170, R.194, T.205, N.207, G.208, R.209 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:R.194, A:T.205, A:N.207, A:R.209 Salt bridges: A:R.170, A:R.209

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kuriwaki, I. et al., Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2. Bioorg.Med.Chem. (2020)

Release Date

2020-04-08

Peptides

Fibroblast growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fibroblast growth factor receptor 2

Related Entries With Identical Sequence